Krishna Institute of Medical Sciences Share Price Live
Live Krishna Institute of Medical Sciences Share Price Chart
O H L VOL
Krishna Institute of Medical Sciences Performance
Krishna Institute Of Medical Sciences Ltd FAQs
What is the share price of Krishna Institute Of Medical Sciences Ltd (KIMS) shares?
Krishna Institute Of Medical Sciences Ltd (KIMS) share price as of December 24, 2024, on NSE is Rs 598.9 (NSE) and Rs 598.9 (BSE) on BSE.
Can I buy Krishna Institute Of Medical Sciences Ltd (KIMS) from Angel One?
Yes, You can buy Krishna Institute Of Medical Sciences Ltd (KIMS) shares by opening a Demat account with Angel One.
How do I buy Krishna Institute Of Medical Sciences Ltd (KIMS) from Angel One?
Krishna Institute Of Medical Sciences Ltd (KIMS) share can be bought through the following modes:
1. Direct investment: You can buy Krishna Institute Of Medical Sciences Ltd (KIMS) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Krishna Institute Of Medical Sciences Ltd (KIMS) shares.
1. Direct investment: You can buy Krishna Institute Of Medical Sciences Ltd (KIMS) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Krishna Institute Of Medical Sciences Ltd (KIMS) shares.
What is the main business of KIMS?
KIMS' main line of business is healthcare. It runs hospitals and medical centres that offer a variety of services including diagnosis, treatment, and surgery.
Who are the promoters of KIMS?
The promoters of KIMS (Krishna Institute of Medical Sciences) mainly include B Bhaskar Rao, Bhaskara Rao Bollineni, Bollineni Ramanaiah Memorial Hospitals Pvt Ltd, Seenaiah Bollineni and others.
What are the Subsidiaries that comes under KIMS?
KIMS Hospitals, KIMS Lifesciences, KIMSHEALTH East, KIMSHEALTH West, and KIMSHEALTH Global are all subsidiaries of KIMS (Krishna Institute of Medical Sciences).